Correlation Between Puma Biotechnology and Annovis Bio

Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and Annovis Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and Annovis Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Puma Biotechnology and Annovis Bio, you can compare the effects of market volatilities on Puma Biotechnology and Annovis Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of Annovis Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and Annovis Bio.

Diversification Opportunities for Puma Biotechnology and Annovis Bio

-0.3

Correlation Coefficient

Puma Biotechnology  Annovis Bio

Very good diversification

The 3 months correlation between Puma and Annovis is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and Annovis Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Annovis Bio and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with Annovis Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annovis Bio has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and Annovis Bio go up and down completely randomly.

Pair Corralation between Puma Biotechnology and Annovis Bio

Given the investment horizon of 90 days Puma Biotechnology is expected to under-perform the Annovis Bio. But the stock apears to be less risky and, when comparing its historical volatility, Puma Biotechnology is 1.99 times less risky than Annovis Bio. The stock trades about -0.01 of its potential returns per unit of risk. The Annovis Bio is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  1,302  in Annovis Bio on October 5, 2024 and sell it today you would lose (791.00) from holding Annovis Bio or give up 60.75% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Puma Biotechnology  vs.  Annovis Bio

Puma Biotechnology

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Puma Biotechnology are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Puma Biotechnology demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Annovis Bio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Annovis Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Puma Biotechnology and Annovis Bio

The main advantage of trading using opposite Puma Biotechnology and Annovis Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, Annovis Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annovis Bio will offset losses from the drop in Annovis Bio's long position.

The idea behind Puma Biotechnology and Annovis Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.